Carregant...
Treatment for metastatic adenocarcinoma of the stomach and gastroesophageal junction: 2020
Gastric and gastroesophageal junction (GEJ) cancer is one of the most common malignancy worldwide. In unresectable or metastatic disease, the prognosis is poor and is generally less than a year. Standard front-line chemotherapy includes two- or three-drug regimens with the addition of trastuzumab in...
Guardat en:
| Publicat a: | Ann Transl Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7575962/ https://ncbi.nlm.nih.gov/pubmed/33145328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-1159 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|